Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Affigen SARL logo — Antibodies, Elisa and PCR Assays, Recombinant Proteins, Plas...

Affigen SARL

Antibodies, Elisa and PCR Assays, Recombinant Proteins, Plasmids, Viral Controls, Cell Culture Media, Cell lines.

Founded 2003 Tunisia Tunisia 6 employees Series A Total: $17.00M Biotechnology, Pharmaceutical

General Information

Company Name Affigen SARL
Founded Year 2003
Location Tunisia Tunisia +1
Employees 6
Industries Biotechnology, Pharmaceutical
Funding Stage Series A
Social

Get notified when Affigen SARL moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Affigen SARL

Affigen is a promising startup in the Biotechnology and Pharmaceutical industries, founded in 2016. The company recently received a significant $17.00M Series A investment on 21 February 2017 from Black Beret Life Sciences. This investment underscores the confidence that Black Beret Life Sciences has in Affigen's potential for growth and innovation in the biotech and pharmaceutical sectors. Such a considerable investment is a testament to the promising capabilities and products that Affigen is developing, and it paves the way for further scalability and market impact. This strong financial backing will undoubtedly fuel Affigen's efforts to advance their cutting-edge technologies and make a lasting mark in the biotech and pharmaceutical landscapes.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 1
Investor
21 Feb 2017

Affigen SARL Alternatives & Competitors

Affigen SARL vs
Calico Biolabs
Calico Biolabs

Collaborating with diagnostic and pharmaceutical leaders to create bespoke rabbit monoclonal antibod...

Biotechnology, Information Technology
Affigen SARL vs
Ablexis, LLC
Ablexis, LLC United States

A superior, next generation transgenic platform.

Series A
1 employees
Biotechnology, Health Care
Affigen SARL vs
Syd Labs, Inc.
Syd Labs, Inc. United States

Syd Labs, a recombinant company based in Boston, Massachusetts, is dedicated to providing quality pr...

5 employees
Biotechnology

FAQ About Affigen SARL

Antibodies, Elisa and PCR Assays, Recombinant Proteins, Plasmids, Viral Controls, Cell Culture Media, Cell lines.
Affigen SARL was founded in 2003.
Affigen SARL is headquartered in Tunisia.
Affigen SARL operates in the following industries: Biotechnology, Pharmaceutical.
Affigen SARL has approximately 6 employees.
Affigen SARL has completed 1 funding round, raising a total of $17.00M. The latest funding stage is Series A.
Top alternatives and competitors to Affigen SARL include Calico Biolabs, Ablexis, LLC, Syd Labs, Inc., AbMax Biotechnology Co.,Ltd., RevMAb Biosciences USA, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Affigen SARL and Calico Biolabs are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Affigen SARL and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy